Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Multiple Sclerosis Drugs News Monitoring

Get by Email • RSS

Published on 06:00 GMT

Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to both treat non-relapsing secondary progressive multiple …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on 07:49 GMT

Sanofi Tolebrutinib under USFDA priority review for multiple sclerosis

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to slow disability …

Source: Medical Dialogues - Uncategorized
Published on 00:00 GMT

‘I just leaned in and did my best’: Spreading awareness about Multiple Sclerosis

WILMINGTON, N.C. (WECT) - March is recognized as multiple sclerosis (MS) awareness month. One woman is shining a light on MS and sharing a message of hope for others. According to the National Multiple Sclerosis Society, nearly 1 million Americans are …

Source: WECT TV6 - North Carolina - Label Pending
Published on Mar 24, 2025

Challenges and Trust in Telehealth Integration for Multiple Sclerosis Care: Enrique Alvarez, MD, PhD

WATCH TIME: 4 minutes "As technology gets better, I think we’ll also have more stability in the measures. The challenge we really have in that regard is just knowing what the best measures are to look at. Technology can measure a lot of things, but …

Source: NeurologyLive - Label Pending
Published on 07:37 GMT

Novartis To Present New Data At AAN, Including Seven-Year Disability Outcomes And Safety Analysis Of Kesimpta® In People ...

(MENAFN- PR Newswire) Long-term disability and safety data from ALITHIOS open-label extension study on continuous treatment with Kesimpta vs. later switch from teriflunomide in relapsing multiple sclerosis (RMS) patients to be presented Additional …

Source: MENAFN - Uncategorized
Published on Mar 24, 2025

Conference MDAngle: AAN 2025 Relapsing-Remitting Multiple Sclerosis

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The 2025 Annual Meeting of the American Academy of Neurology …

Source: Medscape - Neutral
Published on Mar 24, 2025

Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple ...

Urinary symptoms represent a significant source of distress and disability in multiple sclerosis (MS), but the factors influencing their occurrence and exacerbation remain unclear. Frailty has been proposed as a measure of clinical complexity in MS and has …

Source: UroToday - Neutral
Published on Mar 24, 2025

Can ibogaine repair brain damage in multiple sclerosis? New case reports spark interest

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment using a naturally derived substance called ibogaine appeared to improve symptoms and brain health in two individuals with multiple …

Source: PsyPost - Neutral
Published on Mar 24, 2025

Addressing Persistent Challenges in NMOSD Diagnosis and Treatment: Sumaira Ahmed

WATCH TIME: 4 minutes "We need to continue raising awareness of the fact that there are 4 FDA-approved therapies designed for [patients with NMOSD who have] aquaporin-4 positivity, so that hopefully they can get on those drugs and be relapse-free …

Source: NeurologyLive - Neutral
Published on Mar 23, 2025

In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.

For the first time, a clinical trial has demonstrated that taking high doses of vitamin D may slow the progression of multiple sclerosis. In general, taking too much vitamin D can be dangerous; however, the high doses in the new trial were taken in …

Source: LiveScience - Neutral
Published on Mar 23, 2025

All you need to know about: multiple sclerosis

Members of Multiple Sclerosis Society of India forming a ‘human chain’ in Bangalore. File photograph Multiple sclerosis (MS) is a long-term condition that affects the brain and spinal cord. It can cause a wide range of symptoms, such as difficulty in …

Source: The Hindu - Center-left
Published on Mar 22, 2025

Revolutionizing CBD treatment for epilepsy and multiple sclerosis

Cannabidiol (CBD) is popularly used for its painkilling, anti-inflammatory, and neuroprotective effects. It has been used to treat illnesses like epilepsy and multiple sclerosis. But there has been one key limitation preventing it from being used to its …

Source: Earth.com - Neutral
Published on 00:01 GMT

Ray Meade: 'When they told me I had MS, I thought I was done'

Pauline McLeanBBC Scotland Arts Correspondent ShareSave Raymond Meade, who has played with Ocean Colour Scene, was diagnosed with MS in 2021 Like most of us, guitarist Raymond Meade had a slow and quiet summer in 2021. The pandemic had put a stop to live …

Source: BBC - Public Broadcaster
Published on 10:53 GMT

I told the doctor my symptoms, then I saw an eye roll

I had numb patches, the feeling of a feather tickling my face, or ants on my skin (Picture: Maxim Vinciguerra/Infinity Focus) The GP looked over his glasses, smirked, and then started to laugh.   ‘We may need to name a special little syndrome for you …

Source: Metro - Neutral
Published on Mar 21, 2025

Updates on Guidance for Diagnosing Pediatric and Late-Onset Multiple Sclerosis: Andrew Solomon, MD

WATCH TIME: 8 minutes “The diagnostic process [for multiple sclerosis] should be thinking about our diagnostic criteria and making sure that patients fulfill that criteria but also considering other diagnoses that can mimic [the disease] along the way.” …

Source: NeurologyLive - Neutral
Published on 08:08 GMT

Raising awareness of epilepsy

With Epilepsy Awareness Day taking place on March 26, one Central Coast resident who lives with the condition has praised Social Futures for the support it offers. Epilepsy can affect anyone, at any age, and is still widely misunderstood. Supporters are …

Source: Coast Community News - Neutral
Published on 02:59 GMT

First in State: Prestigious Certification in Spine Surgery

UC San Diego Health has once again earned The Joint Commission’s Gold Seal of Approval® for Advanced Certification in Spine Surgery (ACSS), validating its leadership in delivering top-tier spine and neurological care. This prominent certification reflects …

Source: Newswise - Neutral
Published on 10:55 GMT

TFS HealthScience Appoints Miriam Martin as Vice President of Business Development, Clinical Development Services

LUND, Sweden, March 25, 2025 /PRNewswire/ — TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is pleased to announce that Miriam Martin, a long-standing member of the organization, has been appointed Vice President of …

Source: The AI Journal - Label Pending
Published on 10:09 GMT

On an ancient scourge and modern interventions

Tuberculosis patients receiving treatment at the Govind Ballabh Pant Hospital in Agartala. Photograph used for representational purposes only. | Photo Credit: ANI On battling tuberculosis in India, the impact of space flight on human health, rising …

Source: The Hindu - Center-left

06 days 16:45:50

Featured Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 06:30 GMT

Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan

- Alumis to receive $40 million in upfront and near-term co-development payments, with potential for approximately $140 million in additional milestone and field option payments, plus tiered royalties on future sales -Deal underscores the commercial …

Distribution channels: Technology ...
Published on March 25, 2025 - 10:01 GMT

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 …

Distribution channels:

Published on March 25, 2025 - 06:00 GMT

NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel ...

Company presented clinical and preclinical data at the MDA Conference last week in Dallas, Texas Oral presentation included data from MuSK-MG rat model depicting increases in muscle function and improvements in the structural integrity of the neuromuscular …

Distribution channels: Media, Advertising & PR, Technology ...
Published on March 25, 2025 - 03:13 GMT

Lawsuit Notice: Investors who hold Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares should contact the Shareholders ...

SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Investors who purchased shares of Regeneron Pharmaceuticals, …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on March 24, 2025 - 13:44 GMT

Peptic Ulcer Drugs Market to Reach USD 54.8 Billion by 2032 – Persistence Market Research

The global peptic ulcer drugs market is set to grow from USD 42.6 Bn in 2025 to USD 54.8 Bn by 2032, registering a CAGR of 3.2% during the forecast period. LOS ANGELES, CA, UNITED STATES, March 24, 2025 /⁨EINPresswire.com⁩/ -- Peptic ulcers are a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 00:05 GMT

Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder

Tokyo, Japan and Cambridge, UK, 25 March 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGluR5 negative …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 24, 2025 - 23:12 GMT

American Botanical Pharmacy - 562180 - 10/30/2018

Product: Biologics Cosmetics Drugs Blood Products Gene Therapy Deodorant Face Paint Antibiotic Resistance Compounding Issue: Topics Premarket Public Awareness Recipient: Recipient Name Dr. Richard Schulze American Botanical Pharmacy 4114 Glencoe Ave Marina …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on March 24, 2025 - 21:36 GMT

Bingbing Pharmaceutical Co., Ltd - 584327 - 10/03/2019

Delivery Method: VIA UPS Product: Drugs Recipient: Recipient Name Mr. Zhimin Yu Recipient Title President Bingbing Pharmaceutical Co., Ltd No. 698 Bingbing Road Economic Development Zone Shiyan Shi Hubei Sheng, 442500 China Issuing Office: Center for Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 796,904,318 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 03/19/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on March 25, 2025 - 11:00 GMT

Dean Melissa Perry appointed to prestigious National Academies of Sciences, Engineering, and Medicine Committee

Perry appointed to NASEM Committee on Clinical Follow-Up and Care for Those Impacted by the JP-5 Releases at Red Hill. FAIRFAX, VA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- As a widely respected researcher and public health leader, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

LarmorBio Announces Addition of Multiple New Board Members and Senior Executive Hires

Company Prepares to Scale Business with Proprietary Microscale Magnetic Resonance Technology BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- LarmorBio, a Massachusetts Institute of Technology (MIT) start-up pioneering the use of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 11:00 GMT

Enkrypt AI Launches New Multimodal AI Security Solution to Safeguard Text, Image, and Voice AI Systems

Innovative solution secures multimodal AI systems from emerging security, bias, and compliance risks BOSTON, MA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI, a leader in AI security and compliance – is proud to announce the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on March 25, 2025 - 11:00 GMT

CMTA’s $300K Investment in CRISPR for CMT2A

CMTA invests $300K in CRISPR gene editing for CMT2A at UCSF’s Gladstone Institutes, targeting MFN2 mutations to restore nerve function. GLENOLDEN, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

Feroot Launches PaymentGuard AI: Automated PCI DSS 4 Compliance for Websites with E-commerce Payment Webpages.

PaymentGuard AI by Feroot Security: Automating PCI DSS 4 Compliance with Requirements 6.4.3 and 11.6.1 for SAQ D and SAQ A-EP E-Commerce Merchants. TORONTO, CANADA, March 25, 2025 /⁨EINPresswire.com⁩/ -- Feroot Security, a leader in cybersecurity …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:45 GMT

PUSH for Empowered Pregnancy Launches #MomentForStillness to Honor Babies Born Still and Demand Urgent Action

A Nationwide Call to Address Preventable Stillbirths Begins March 25th at Noon ET NEW YORK, NY, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PUSH for Empowered Pregnancy is launching the #MomentForStillness campaign at noon ET on Tuesday, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:18 GMT

TravelingWiki Foundation Launches 'Card For a Cause' to Leverage Sports Cards for Free Non Visible Disability Resources

TravelingWiki Now Offers Free Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian DES MOINES, IA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- TravelingWiki …

Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:00 GMT

PhenoBiome Welcomes New Leadership and Validates Breakthrough Microbiome Modulation

Brian Russon Named CEO, Kait Mikes Appointed COO as Company Advances Clinical Validation of Predictive Platform PALM SPRINGS, CA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- PhenoBiome, Inc., a pioneering leader in personalized …

Distribution channels: Business & Economy, Food & Beverage Industry ...
Published on March 25, 2025 - 09:45 GMT

Florida Mesothelioma Victims Center Has Endorsed the Gori Law Firm for a Former Power Plant Worker with Just Diagnosed ...

TAMPA , FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Florida Mesothelioma Victims Center says, "We have endorsed, and we highly recommend the Gori Law Firm for a former power plant worker with just diagnosed mesothelioma or …

Distribution channels: Automotive Industry, Building & Construction Industry ...
Published on March 25, 2025 - 09:43 GMT

OmnySense to Target Oncology Patients as Initial Focus for Its Transformative Personal Health-Assessment Solution

19m Americans have cancer. Unplanned acute visits drive nearly half the costs-creating a major unmet need and opportunity for innovative solutions TEL AVIV, ISRAEL, March 25, 2025 /⁨EINPresswire.com⁩/ -- OmnySense, an innovative digital health …

Distribution channels: Banking, Finance & Investment Industry, Emergency Services ...
Published on March 25, 2025 - 08:17 GMT

RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science

RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /⁨EINPresswire.com⁩/ -- RSU Research Week 2025 opened on 24 …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 08:09 GMT

Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group

The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /⁨EINPresswire.com⁩/ -- The Board of Atlas Antibodies Group is pleased to announce …

Distribution channels: Business & Economy, Chemical Industry ...
Published on March 25, 2025 - 07:36 GMT

A' Wellness, Health Promotion, and Preventive Care Design Award Announces Comprehensive Prize Package for 2024

The prestigious A' Wellness, Health Promotion, and Preventive Care Design Award reveals an extensive array of benefits for 2024 competition laureates COMO, CO, ITALY, March 25, 2025 /⁨EINPresswire.com⁩/ -- The A' Wellness, Health Promotion …

Distribution channels: Business & Economy, Consumer Goods ...
Published on March 25, 2025 - 05:24 GMT

Unlocking the Potential of Tofacitinib: New Frontiers in Treating Skin Disorders

BRADENTON, FL, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Skin disease related to immune system problems can be a challenge to treat. A new drug, Tofacitinib has gained attention for its therapeutic effects in autoimmune and inflammatory …

Distribution channels: Beauty & Hair Care, Education ...
Published on March 25, 2025 - 05:08 GMT

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA

Acclaim Autism Opens New Early Childhood ABA Therapy Center in Lancaster, PA: Empowering young children with autism through individualized therapy. LANCASTER, PA, UNITED STATES, March 25, 2025 /⁨EINPresswire.com⁩/ -- Acclaim Autism is thrilled to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on March 24, 2025 - 23:15 GMT

Helvetic Dental Clinics en Hongrie célèbre une année record en 2024 en tant que meilleure clinique dentaire de Budapest

Helvetic Dental Clinics, la meilleure clinique dentaire en Hongrie, termine 2024 sur un bilan record et agrandit sa capacité avec l’ajout de quatre fauteuils. BUDAPEST, BUDAPEST, HUNGARY, March 25, 2025 /⁨EINPresswire.com⁩/ -- Helvetic Dental …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on March 24, 2025 - 23:12 GMT

Chasin A Dream Foundation’s Annual Gala Raises Over $550,000 for Local Children Battling Life-Threatening Illnesses

The Jupiter based foundation's annual gala was an unforgettable evening of generosity and impact, breaking a record with $550,000 raised. JUPITER, FL, UNITED STATES, March 24, 2025 /⁨EINPresswire.com⁩/ -- Chasin A Dream Foundation’s annual …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...
Published on March 24, 2025 - 22:57 GMT

Study Validates Effectiveness of KYAN Tech's Platform for Combination Therapy Prediction and Target Discovery in Sarcoma

Groundbreaking study published in npj Precision Oncology highlights Optim.AI’s potential to revolutionize personalized cancer treatment strategies SINGAPORE, SINGAPORE, March 24, 2025 /⁨EINPresswire.com⁩/ -- KYAN Technologies Pte. Ltd. (“KYAN”) …

Distribution channels: Companies, Education ...
Published on March 25, 2025 - 10:30 GMT

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

WAYNE, Pa., March 25, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR study were presented at the 40th Annual European Association of Urology ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on March 25, 2025 - 10:30 GMT

Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) ...

Based on overall survival data observed in interim analysis in platinum-resistant ovarian cancer, Mural will not progress trial to final analysis Continued demonstration of favorable tolerability profile generally consistent with previously reported data; …

Distribution channels: Healthcare & Pharmaceuticals Industry ...